Glycated haemoglobin levels in patients with multidrug-resistant tuberculosis infection during 6 months of treatment
| Autor: | Arinola Og, KS Akinlade, OM Ige, Sheu Kadiri Rahamon, VF Edem |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty Longitudinal study 030109 nutrition & dietetics Tuberculosis business.industry General Chemical Engineering Nigerians medicine.disease Surgery Multiple drug resistance 03 medical and health sciences Regimen Diabetes mellitus Glycaemic change Glycated haemoglobin Multidrug resistant tuberculosis therapy Internal medicine Statistical significance Diabetes mellitus medicine Sample collection business |
| Zdroj: | African Journal of Clinical and Experimental Microbiology; Vol 17, No 3 (2016); 173-178 |
| ISSN: | 1595-689X |
| Popis: | Background : There is little information on the possible impact of drugs used in the treatment of multi-drug resistant tuberculosis (MDR-TB) on glycaemic levels. This study therefore assessed changes in glycated haemoglobin levels in patients with MDR-TB. Materials and Methods : This longitudinal study involved 21 MDR-TB patients who were followed up for 6 months. Glycated haemoglobin (HbA1c) level of each patient was determined before the commencement of MDR-TB drug regimen and at 2, 4 and 6 months post treatment as part of a study which investigated them every 2 months. Differences in means were assessed using the paired Student’s t-test and statistical significance was set at P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|